Keywords: ایمونوخموتراپی; Follicular lymphoma; Elderly patients; Rituximab; Immunochemotherapy; Maintenance; Survival;
مقالات ISI ایمونوخموتراپی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: ایمونوخموتراپی; Aggressive lymphoma; Bendamustine; Diffuse large B-cell lymphoma; Immunochemotherapy; Indolent lymphoma;
Keywords: ایمونوخموتراپی; Visceral leishmaniasis; Immunochemotherapy; sodium stibogluconate; Killed Leishmania donovani antigen; MPL-A (Monophosphoryl lipid A);
Role of radiotherapy in patients with limited diffuse large B-cell lymphoma of Waldeyer's ring in remission after R-CHOP immunochemotherapy
Keywords: ایمونوخموتراپی; WR; Waldeyer's ring; NHL; non-Hodgkin's lymphoma; DLBCL; diffuse large B-cell lymphoma; RT; radiotherapy; IFRT; Involved field radiation therapy; CT; immunochemotherapy; PET-CT; positron emission tomography-computed tomography; DFS; disease free survi
Overview on the management of non-gastric MALT lymphomas
Keywords: ایمونوخموتراپی; Non-gastric MALT lymphoma; Extranodal marginal zone lymphoma; Antibiotic therapy; Site-specific treatment; Radiotherapy; Immunochemotherapy;
Primary hepatic diffuse large B-cell lymphoma with favorable response to immunochemotherapy
Keywords: ایمونوخموتراپی; Primary hepatic lymphoma; Diffuse large B-cell lymphoma; Immunochemotherapy;
Research paperHigh serum levels of soluble interleukin-2 receptor (sIL2-R), interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF) are associated with adverse clinical features and predict poor outcome in diffuse large B-cell lymphoma
Keywords: ایمونوخموتراپی; Diffuse large B-cell lymphoma; Cytokines; Immunochemotherapy; Outcome; Toxicity;
A combination of nanosystems for the delivery of cancer chemoimmunotherapeutic combinations: 1-Methyltryptophan nanocrystals and paclitaxel nanoparticles
Keywords: ایمونوخموتراپی; 1-Methyltryptophan; Nanocrystals; Paclitaxel; Nanoparticles; Immunochemotherapy;
Diffuse Large B-Cell Lymphoma in the Elderly: Real World Outcomes of Immunochemotherapy in Asian Population
Keywords: ایمونوخموتراپی; Asian; DLBCL; Immunochemotherapy; Older patients; Prognosis;
R-CHOP therapy alone for limited-stage follicular lymphoma
Keywords: ایمونوخموتراپی; Follicular lymphoma; Immunochemotherapy; Limited-stage; Rituximab; R-CHOP;
The outcome of primary mediastinal B-cell lymphoma in a single center experience
Keywords: ایمونوخموتراپی; Primary mediastinal B-cell lymphoma; Immunochemotherapy; Autologous hematopoietic stem cell transplantation; Radiotherapy; Outcomepierwotny chłoniak śródpiersia z komórek B; immunochemioterapia; autologiczny przeszczep komórek macierzystych układu krwiotw
Clinical efficacy of protein-bound polysaccharide K in patients with gastric cancer undergoing chemotherapy with an oral fluoropyrimidine (S-1)
Keywords: ایمونوخموتراپی; Gastric cancer; Immunochemotherapy; Neutrophil to lymphocyte ratio; Oral fluorouracil anticancer drug; Protein-bound polysaccharide-K
Chłoniak rozlany z dużych limfocytów B – czy R-CHOP-21 jest leczeniem optymalnym?
Keywords: ایمونوخموتراپی; chłoniak rozlany z dużych komórek B; immunochemioterapia; patogeneza; terapia celowana; chorzy w podeszłym wiekuDiffuse large B-cell lymphoma; Immunochemotherapy; Pathogenesis; Targeted therapy; Elderly patients
La maladie de Waldenström ou macroglobulinémie
Keywords: ایمونوخموتراپی; Maladie de Waldenstrom; Macroglobulinémie; IgM monoclonale; syndrome lymphoprolifératif chronique; Waldenstrom's macroglobulinemia; immunochemotherapy; MYD88; monoclonal IgM;
ChÅoniak z komórek pÅaszcza u pacjentów niekwalifikujÄ
cych siÄ do chemioterapii w wysokich dawkach
Keywords: ایمونوخموتراپی; chÅoniak z komórek pÅaszcza; diagnostyka; immunochemioterapia; Mantle cell lymphoma; Diagnosis; Immunochemotherapy;
ChÅoniak grudkowy: rozpoznawanie i leczenie
Keywords: ایمونوخموتراپی; chÅoniak grudkowy; strategia leczenia; immuochemioterapia; Follicular lymphoma; Diagnosis; Treatment strategy; Immunochemotherapy;
Un cas atypique de lymphome malin non hodgkinien primitif du corps utérin
Keywords: ایمونوخموتراپی; Lymphome malin primitif; Corps utérin; Bilan d'extension; Immuno-chimiothérapie; Primary malignant lymphoma; Uterine body; Staging; Immunochemotherapy;
Interstitial Pneumonia After Autologous Hematopoietic Stem Cell Transplantation in B-Cell Non-Hodgkin Lymphoma
Keywords: ایمونوخموتراپی; Autologous stem cell transplantation; Immunochemotherapy; Interstitial pneumonia; Malignant lymphoma; Rituximab; Toxicity
Leishmaniasis vaccines: past, present and future
Keywords: ایمونوخموتراپی; Vaccine; Leishmaniasis; Prophylaxis; Immunotherapy; Immunochemotherapy; Emerging infectious disease
How to improve the treatment outcome in chronic lymphocytic leukemia?
Keywords: ایمونوخموتراپی; Chronic lymphocytic leukemia; Purine nucleoside analogs; Mitoxantrone; Rituximab; Immunochemotherapy; Minimal residual disease; New drugs; Hematopoietic cell transplantation;
Front-line High-Dose Chemotherapy with Rituximab Showed Excellent Long-Term Survival in Adults with Aggressive Large B-Cell Lymphoma: Final Results of a Phase II GOELAMS Study
Keywords: ایمونوخموتراپی; Aggressive lymphoma; High-dose therapy; Autologous stem cell transplant; Immunochemotherapy
Immunotherapy with the saponin enriched-Leishmune® vaccine versus immunochemotherapy in dogs with natural canine visceral leishmaniasis
Keywords: ایمونوخموتراپی; Canine visceral leishmaniasis; Kala-azar; Leishmania chagasi; Leishmune®; Saponin; Immunotherapy; Immunochemotherapy; Allopurinol; Amphotericin B
Prognostic impact of CD31-positive microvessel density in follicular lymphoma patients treated with immunochemotherapy
Keywords: ایمونوخموتراپی; FL; Angiogenesis; Prognosis; Immunochemotherapy
The emergence of immunomodulation: Combinatorial immunochemotherapy opportunities for the next decade
Keywords: ایمونوخموتراپی; Combinatorial; Immunochemotherapy; Ovarian cancer
The use of pH-triggered leaky heterogeneities on rigid lipid bilayers to improve intracellular trafficking and therapeutic potential of targeted liposomal immunochemotherapy
Keywords: ایمونوخموتراپی; Liposome; pH-triggered; Immunochemotherapy; Heterogeneous membranes
Rzadki przebieg chÅoniaka z komórek B jamy nosowej - opis przypadku
Keywords: ایمونوخموتراپی; chÅoniak rozlany z dużych komórek B; jama nosowa; skóra; immunochemioterapia; radioterapia; DLBCL-lymphoma; nose cavity; skin; immunochemotherapy; radiotherapy;
Evaluation of an immunochemotherapeutic protocol constituted of N-methyl meglumine antimoniate (Glucantime®) and the recombinant Leish-110f® + MPL-SE® vaccine to treat canine visceral leishmaniasis
Keywords: ایمونوخموتراپی; Leishmania chagasi; Leishmaniasis; Canine visceral leishmaniasis; Immunochemotherapy
Reactivation of an occult hepatitis B virus escape mutant in an anti-HBs positive, anti-HBc negative lymphoma patient
Keywords: ایمونوخموتراپی; HBV; Reactivation; Escape mutant; Anti-HBs; Anti-HBc; HBV DNA; HBsAg; Lymphoma; Immunosuppression; Immunochemotherapy
Histologic Subtype of Metastatic Renal Cell Carcinoma Predicts Response to Combined Immunochemotherapy with Interleukin 2, Interferon α and 5-Fluorouracil
Keywords: ایمونوخموتراپی; Papillary renal cell carcinoma; Immunochemotherapy; Interleukin 2; Interferon α; 5-Fluorouracil
Rituximab maintenance therapy in indolent NHL: a clinical review
Keywords: ایمونوخموتراپی; Rituximab; Maintenance therapy; Follicular lymphoma; Immunochemotherapy;
Anticorps monoclonal anti-CD20 (rituximab) dans les maladies hématologiques et les affections auto-immunes
Keywords: ایمونوخموتراپی; Rituximab; Lymphomes non-Hodgkiniens; Maladies auto-immunes; Cytopénies immunitaires; Leucémie lymphoïde chronique; Immunochimiotherapie; Polyarthrite rhumatoïde; Rituximab; NHL; Autoimmune diseases; Immune cytopenia; Chronic lymphoid leukemia; Immuno
Tolerability and safety of rituximab (MabThera®)
Keywords: ایمونوخموتراپی; Rituximab; CD20; Immunotherapy; Immunochemotherapy; Non-Hodgkin's lymphoma; Chronic lymphocytic leukaemia; Rheumatoid arthritis;